Primary Recommendation

Medica - Sets up advanced practitioner radiography network alongside radiologist one

May 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

The “teleradiology” industry was first pioneered in the US in 1993 when an Idaho radiologist launched Nighthawk. This service enabled images such as CT and MRI scans to be sent from the hospital where they were created to an offsite consultant radiologist for remote interpretation, offering huge benefits for patients and healthcare providers alike. What began as a cottage industry to provide remote image interpretations by radiologists who were willing to work nights blossomed as it began to offer day reads also. “Nighthawk” became the eponymous word for off hours, remote x-ray interpretation, a bit like Xerox for photocopying.Where the US goes, the UK often follows and Medica was set up in 2004 when it beca ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Market Comment - May '17

Curtis Banks Group - Very high level of repeat income

Medica - Bid at 212p (May 2023)

Medica - Moves into US$1bn US clinical trials market (May 2021)

Medica (November 2020)

Medica Group (August 2020)

Medica (September 2018)

Medica - Radiology recruitment jumps in Q2 (May 2018)

Medica (February 2018)

Medica (November 2017)

Medica - Hot telehealth new issue (April 2017)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X